Meningitis vaccine approved for California college

Health officials at a Southern California college will start offering a vaccine against bacterial meningitis after an outbreak in November.

Officials at the University of California, Santa Barbara said Friday that federal health regulators have approved the vaccine for use on campus. The vaccine is approved for use overseas but is not yet approved for general use in the United States.

The move comes after Princeton University last year received permission to dole out the after eight students became infected.

Four students at Santa Barbara fell ill in November. Three recovered and the fourth had both feet amputated. No new cases have been diagnosed.

Meningococcal disease can be spread among people in dormitories and other crowded settings.

The university plans to hold a two-week vaccination clinic in late February.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Princeton vaccine reaches 90 percent of eligible

Dec 13, 2013

Princeton University officials say more than 90 percent of the eligible students and staff received a meningitis vaccine this week as part of the university's effort to halt an outbreak.

Recommended for you

WHO: Millions of Ebola vaccine doses ready in 2015

21 hours ago

The World Health Organization says millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines will start being tested in March.

Added benefit of vedolizumab is not proven

Oct 23, 2014

Vedolizumab (trade name Entyvio) has been approved since May 2014 for patients with moderately to severely active Crohn disease or ulcerative colitis. In an early benefit assessment pursuant to the Act on the Reform of the ...

Seaweed menace may yield new medicines

Oct 22, 2014

An invasive seaweed clogging up British coasts could be a blessing in disguise. University of Greenwich scientists have won a cash award to turn it into valuable compounds which can lead to new, life-saving drugs.

User comments